SeraCare Expands AccuPlex Technology Portfolio with HCV RNA Linearity Panel
August 26, 2018 - SeraCare Life Sciences, Milford, Mass, is launching its new AccuSpan HCV RNA linearity panel, the latest product built with the company’s proprietary AccuPlex recombinant technology. Qualified against World Health Organization standards, the eight-member panel is made from serial dilutions of high-titer recombinant hepatitis C virus (genotype 1b) with established reactivity for HCV RNA, and one negative member.